Revolutionizing Alcohol Detection: SOBR Safe Secures $8.2 Million in Funding

SOBR Safe is excited to announce that it has successfully raised $8,199,999 in funding to further its mission of combating alcohol misuse and enhancing public health safety. As the fourth leading cause of preventable death in America, alcohol misuse presents a critical challenge that demands innovative solutions. Current monitoring methods are often invasive, inefficient, and unhygienic, creating barriers for effective detection and intervention. SOBRsafe™ addresses these issues head-on with its groundbreaking transdermal technology, which allows for instantaneous and non-invasive detection of alcohol through the skin. This advanced system not only eliminates the need for breath, blood, or urine samples but also utilizes a robust backend data platform that enhances monitoring capabilities across various sectors, including behavioral health, the judicial system, and consumer markets. The newly acquired funds will be directed towards expanding the commercial availability of SOBRcheck, our point-of-care screening tool, and SOBRsure, our continuous monitoring solution. By advancing these technologies, SOBRsafe aims to establish a culture of prevention and support, helping to reduce the prevalence of alcohol misuse and its associated harms. This funding marks a significant milestone in our journey, empowering us to innovate and connect with communities in need. We invite everyone to learn more about SOBRsafe and our commitment to public health by visiting www.sobrsafe.com. Together, we can create a healthier future.